Closed
Source verified July 8, 2026
Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024
Collaborative R&D support for Canadian SMEs
Funding available
$ 500,000
Deadline
July 12, 2024
Location
Canada
Who can apply
Incorporated, profit-oriented small or medium-sized businesses in Canada
See full eligibility
Overview
The Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 supports Canadian SMEs working with a foreign MNC through international collaborative R&D, offering up to 50% reimbursement up to $75,000 CAD for Phase 1 and up to $500,000 CAD for Phase 2. It targets biomanufacturing and health sciences projects, including technology co-development, validation or adaptation in vaccines and therapeutics, pharmaceuticals, or diagnostics.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop a new product or service
- Conduct research and development activities
Eligible Funding
- Maximum amount : 500,000 $
- Up to 50% of project cost
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- For-profit business
Annual revenue
- $ 500,000 minimum revenue
Organisation size
- 15-500 employees
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Proof-of-Concept (PoC) projects
- Research and development (R&D) collaboration projects
- Technology co-development, validation or adaptation of an innovative product, process or technology-based service
Documents Needed
- Foreign MNC partner’s Letter of Intent (LoI) or written confirmation of partner engagement in the project
- International Project Report
- MOU or LoI with the foreign partner as proof of partnership
Official resources
Eligibility
Who is eligible?
- Incorporated, profit-oriented small or medium-sized businesses in Canada
- Canadian SME participants registered as NRC IRAP clients
Who is not eligible
- Canadian SMEs that are not eligible for funding as NRC IRAP clients
- Foreign corporate partners with an existing contractual sales or procurement contract in place with the Canadian SME for the work outlined in the proposed project
Selection criteria
- Preference may be given to SME applicants with a minimum of 15 full-time equivalent employees.
- Preference may be given to SME applicants who have commercialized 1 or more products domestically or internationally.
- Preference may be given to SME applicants with greater than $500,000 CAD in annual revenue.
How to apply
- Register using the Register button at the end of the page.
- Provide basic information about the applicant and the MNC partner upon registration.
- Submit the proof-of-concept (PoC) project form with information on the applicant, the project idea, the technology and markets, and the foreign MNC partner’s Letter of Intent or written confirmation of engagement.
- In exceptional cases, request permission to forgo Phase 1 through an exemption request with your NRC IRAP representative.
- After successful completion of the PoC project, inform your NRC IRAP representative to advance to Phase 2, then complete the International Project Report and submit the R&D collaboration project form with a MOU or LoI.
Processing and Agreement
- NRC IRAP will review registrations and contact applicants if more information is required.
- Qualifying applicants will be invited to submit a proof-of-concept project form.
- PoCs will be evaluated by the applicant’s NRC IRAP representative and the NRC IRAP International Office.
- Successful and selected Canadian SMEs will work with their NRC IRAP representative to prepare an NRC IRAP Proposal for Small Projects and contribution agreement, and must fulfill NRC IRAP Level 1 of the IP Assist Program.
- The International Project Report will be evaluated by an NRC IRAP team, and qualifying applicants will be invited to submit an R&D collaboration project.
- Selected Canadian SMEs must fulfill NRC IRAP Level 2 or 3 of the IP Assist Program for Phase 2.
Contacts
Frequently Asked Questions about the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 Program
What is the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024?
The Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 supports Canadian SMEs working with a foreign MNC through international collaborative R&D, offering up to 50% reimbursement up to $75,000 CAD for Phase 1 and up to $500,000 CAD for Phase 2. It targets biomanufacturing and health sciences projects, including technology co-development, validation or adaptation in vaccines and therapeutics, pharmaceuticals, or diagnostics.
How much funding can be received?
Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 Funds up to 50% of admissible expenses, capped at $500,000 per project.
Who is eligible for the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 program?
To be eligible for the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 program, you must:
The project consortium must include at least 1 eligible Canadian SME and 1 foreign MNC partner.
The Canadian SME must be incorporated, profit oriented, and have 500 or fewer full-time equivalent employees.
The foreign corporate partner must have more than 250 full-time equivalent employees with operations in different countries.
What expenses are eligible under Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024?
Proof-of-Concept (PoC) projects
Research and development (R&D) collaboration projects
Technology co-development, validation or adaptation of an innovative product, process or technology-based service
Who can I contact for more information about the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024?
You can contact National Research Council Canada (NRC) by email at IRAP.International.PARI@nrc-cnrc.gc.ca or by phone at 1-877-994-4727.
Where is the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 available?
The Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 program is available across Canada.
Is the Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 a grant, loan, or tax credit?
Multinational Corporate Collaboration Program: biomanufacturing and health sciences—spring 2024 is a Grant and Funding